BW A868C
a selective DP receptor antagonist; structure given in first source
Also Known As:
3-benzyl-5-(6-carboxyhexyl)-1-(2-cyclohexyl-2-hydroxyethylamino)hydantoin; BW 868C; BW A 868C; BW-A-868C; BW-A868C; BWA868C; 4-Imidazolidineheptanoic acid, 3-((2-cyclohexyl-2-hydroxyethyl)amino)-2,5-dioxo-1-(phenylmethyl)-
Networked: 9
relevant articles (0 outcomes,
1 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Asirvatham-Jeyaraj, Ninitha:
1 article
(12/2019)
|
2. | Burnett, Robert:
1 article
(12/2019)
|
3. | Fink, Gregory D:
1 article
(12/2019)
|
4. | Jones, A Daniel:
1 article
(12/2019)
|
5. | Bek, Toke:
1 article
(08/2015)
|
6. | Kringelholt, Sidse:
1 article
(08/2015)
|
7. | Oversø Hansen, Pernille:
1 article
(08/2015)
|
8. | Simonsen, Ulf:
1 article
(08/2015)
|
9. | Mak, Oi-Tong:
1 article
(11/2011)
|
10. | Wang, Jun-Jie:
1 article
(11/2011)
|
Related Diseases
Related Drugs and Biologics